国产精品亚洲综合一区二区三区|国产暴力强伦轩1区二区小说|老熟女重囗味HDXX69|欧美综合自拍亚洲综合图|粗大的内捧猛烈进出在线视频|亚洲美女又黄又爽在线观看,91久久精品一区二区三区色欲,亚洲欧美久久精品1区2区,日韩免费精品 无码一区不卡

URIT Global New Products Launch at Medlab 2025

Date de publication::2025/02/05

On the afternoon of February 4th, URIT hosted a grand Global Product Launch at the Conrad Dubai Hotel, unveiling a series of next-generation medical technologies to over 150 global clients and partners. This exclusive event provided a comprehensive look at the innovative features and advancements driving URIT’s new products, showcased through high-definition live demos across three large screens.



The launch ceremony was kicked off by Mr. Jack Huang, URIT Vice President, who reflected on the company’s 40-year journey—from a pioneer in China’s diagnostic industry to a global leader in medical technology. With a proud history of delivering reliable products, including those used in space missions, URIT continues to expand its reach and innovation, offering solutions across urine analysis, blood diagnostics, immunology, and more.


Among the key highlights were the US-5000 Al Modular Urinalysis Workflow, BS-8000 Modular Hematology Workflow, and the BF-730 Flow Cytometer, which garnered praise from medical professionals worldwide for their precision, automation, and user-friendly features. Distinguished medical experts, including Prof. Dr. Zeliha Günnur Dikmen and Dr. Larisa Semenova, shared their experiences with URIT’s products, underscoring their reliability and unmatched performance in clinical settings.Additionally, Dr. Vasileva Elizaveta from Russia introduced the BF-700/710 Flow Cytometer, emphasizing its critical role in HIV detection and other infectious diseases, as well as its precision and low-maintenance design.


As we celebrate 40 years of excellence, URIT remains steadfast in its mission to innovate and deliver superior diagnostic solutions, driven by our belief in technology’s power to transform healthcare. The event marked a significant milestone in our global journey, reinforcing our commitment to advancing healthcare worldwide.

Together with our global partners, we look forward to shaping the future of medical diagnostics—one breakthrough at a time.